Partners Capital Investment Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-38,318
| Closed | -$610K | – | 137 |
|
|
2022
Q4 | $610K | Sell |
38,318
-3,076
| -7% | -$49K | 0.03% | 111 |
|
|
2022
Q3 | $677K | Sell |
41,394
-103,895
| -72% | -$1.7M | 0.04% | 111 |
|
|
2022
Q2 | $2.05M | Hold |
145,289
| – | – | 0.14% | 83 |
|
|
2022
Q1 | $3.52M | Sell |
145,289
-79,541
| -35% | -$1.93M | 0.17% | 79 |
|
|
2021
Q4 | $5.25M | Buy |
224,830
+17,546
| +8% | +$410K | 0.24% | 77 |
|
|
2021
Q3 | $3.44M | Buy |
207,284
+85,482
| +70% | +$1.42M | 0.16% | 80 |
|
|
2021
Q2 | $2.97M | Buy |
121,802
+34,691
| +40% | +$846K | 0.13% | 90 |
|
|
2021
Q1 | $2.25M | Buy |
87,111
+47,288
| +119% | +$1.22M | 0.1% | 107 |
|
|
2020
Q4 | $2.13M | Buy |
+39,823
| New | +$2.13M | 0.12% | 90 |
|